Tag: osimertinib
Histologic Transformation From NSCLC to SCLC: A Mechanism of Resistance to...
By Denis Moro-Sibilot, MD, MSc
Posted: April 16, 2020
EGFR tyrosine kinase inhibitors (TKIs) are the standard of care for mutated EGFR NSCLC. Today, one of...
